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We deeply appreciate the great contributions of many physicians in the registry of esophageal cancer cases. The Comprehensive Registry of Esophageal Cancer in Japan, 2009 was published here, despite some delay. The registry complies with the Act for the Protection of Personal Information. The encryption with a HASH function is used for ''anonymity in an unlinkable fashion''.

We briefly summarized the Comprehensive Registry of Esophageal Cancer in Japan, 2009. Japanese Classification of Esophageal Cancer 10th and UICC TNM Classification 6th were used for cancer staging according to the subjected year. A total of 6260 cases were registered from 276 institutions in Japan. Tumor locations were cervical: 4.4 %, upper thoracic: 11.9 %, middle thoracic: 48.0 %, lower thoracic: 27.7 % and EG junction: 6.6 %. Superficial carcinomas (Tis, T1a, T1b) were 36.7 %. As for the histologic type of biopsy specimens, squamous cell carcinoma and adenocarcinoma accounted for 90.5 and 3.8 %, respectively. Regarding clinical results, the 5-year survival rates of patients treated using endoscopic mucosal resection, concurrent chemoradiotherapy, radiotherapy alone, chemotherapy alone, or esophagectomy were 86.2, 27.9, 20.2, 5.8, and 55.9 %, respectively. Esophagectomy was performed in 3844 cases. Concerning the approach used for esophagectomy, 24.9 % of the cases were treated thoracoscopically. The operative mortality (within 30 days after surgery) was 1.01 % and the hospital mortality was 4.76 %.

We hope that this Comprehensive Registry of Esophageal Cancer in Japan, 2009 will help to improve all aspects of the diagnosis and treatment of esophageal cancer in Japan.
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InstitutionsAichi Cancer CenterAizawa HospitalAkita University HospitalAomori Municipal HospitalAomori Prefectural Central HospitalArao Municipal HospitalAsahikawa Medical College HospitalChiba Cancer CenterChiba Medical CenterChiba University HospitalChibaken Saiseikai Narashino HospitalDokkyo Medical University HospitalEhime University HospitalFoundation for Detection of Early Gastric CarcinomaFuchu HospitalFujioka General HospitalFujisawa Shounandai HospitalFujita Health UniversityFukui Prefectural HospitalFukui University HospitalFukuoka Dental College and Dental HospitalFukuoka Saiseikai General Hospital?Fukuoka University HospitalFukuoka Wajiro HospitalFukushima Medical University HospitalFukuyama City HopitalGifu Prefectural General Medical CenterGifu University HospitalGunma Central General HospitalGunma Prefectural Cancer CenterGunma University HospitalGunmaken Saiseikai Maebashi HospitalHachinohe City HospitalHakodate Goryokaku HospitalHakodate National HospitalHamamatsu University School of Medicine, University HospitalHanda City HospitalHannan Chuo HospitalHeartlife HospitalHigashiosaka City General HospitalHino Memorial HospitalHiratsuka City HospitalHiratsuka Kyosai HospitalHirosaki University HospitalHiroshima City Asa HospitalHiroshima University Research Institute for Radiation Biology MedicineHitachi General HospitalHofu Institute of GastroenterologyHokkaido Kin-Ikyo Chuo HospitalHokkaido University HospitalHyogo Cancer CenterHyogo College of MedicineHyogo Prefectural Nishinomiya HospitalIbaraki Prefectural Central HospitalIizuka HospitalImazu Surgical ClinicInazawa City HospitalInternatinal University of Health and Welfare HospitalIsehara Kyodo HospitalIshikawa Prefectural Central HospitalIwakuni Medical CenterIwate Medical University HospitalIwate Prefectural Chubu HospitalIwate Prefectural Isawa HospitalJapanese Red Cross Fukui HospitalJapanese Red Cross Ishinomaki HospitalJapanese Red Cross Kyoto Daini Hospital?Japanese Red Cross Maebashi HospitalJapanese Red Cross Nagaoka HospitalJapanese Red Cross Narita HospitalJapanese Red Cross Nasu HospitalJichi Medical University HospitalJuntendo University HospitalJuntendo University Shizuoka HospitalJunwakai Memorial HospitalKagawa Rosai HospitalKagawa University HospitalKagoshima Kenritsu Satsunan HospitalKagoshima University HospitalKameda General HospitalKanagawa Cancer CenterKanazawa Medical University HospitalKanazawa University HospitalKansai Medical University Hirakata HospitalKansai Rosai HospitalKashiwa Kousei General HospitalKawakita General HospitalKawasaki Medical School HospitalKawasaki Medical School Kawasaki HospitalKawasaki Municipal HospitalKawasaki Municipal Ida HospitalKeio University HospitalKeiyukai Sapporo HospitalKikuna Memorial HospitalKinki Central HospitalKinki University HospitalKiryu Kosei General HospitalKishiwada City HospitalKitaakita Municipal HospitalKitakyushu Municipal Medical CenterKitano HospitalKitasato University HospitalKobe City Medical Center General HospitalKobe University HospitalKochi University HospitalKokura Memorial HospitalKumamoto City HospitalKumamoto University HospitalKurashiki Central HospitalKurume General HospitalKurume University HospitalKuwana West Medical CenterKyoto University HospitalKyushu Central Hospital of the Mutual Aid Association of Public School TeachersKyushu University Beppu HospitalKyushu University HospitalKyushu Medical CenterMachida Municipal HospitalMatsuda HospitalMatsushita Memorial HospitalMatsuyama Red Cross HospitalMie University HospitalMino City HospitalMito Red Cross HospitalMitsui Memorial HospitalMiyazaki Konan HospitalMurakami General HospitalMusashimurayama HospitalMusashino Red Cross HospitalNagahama City HospitalNagano Red Cross HospitalNagaoka Chuo General HospitalNagasaki University HospitalNagayoshi General HospitalNagoya City University HospitalNagoya City West Medical CenterNagoya Daiichi Red Cross HospitalNagoya University HospitalNara Hospital Kinki University Faculty of MedicineNara Medical University HospitalNational Cancer Center HospitalNational Cancer Center Hospital EastNational Center for Global Health and MedicineNational Defense Medical College HospitalNational Hospital Organization Beppu Medical CenterNational Hospital Organization Chiba-East-HospitalNational Hospital Organization Fukuoka-higashi Medical CenterNational Hospital Organization Kure Medical CenterNational Hospital Organization Kyoto Medical CenterNational Hospital Organization Kyushu Cancer CenterNational Hospital Organization Matsumoto National HospitalNational Hospital Organization Nagasaki Medical Center.National Hospital Organization Nagoya Medical CenterNational Hospital Organization Osaka National HospitalNational Hospital Organization Tokyo Medical CenterNiigata Cancer Center HospitalNiigata City General HospitalNiigata Prefectural Shibata HospitalNiigata University Medical and Dental HospitalNikko Memorial HospitalNippon Medical School Chiba Hokusoh HospitalNippon Medical School HospitalNippon Medical School Musashi Kosugi HospitalNippon Medical School Tama Nagayama HospitalNishi-Kobe Medical CenterNishinomiya Municipal Central HospitalNumazu City HospitalObihiro Kousei General HospitalOhta General Hospital Foundation Ohta Nishinouchi HospitalOita Red Cross HospitalOita University HospitalOkayama Saiseikai General HospitalOkayama University HospitalOnomichi Municipal HospitalOsaka City General HospitalOsaka City University HospitalOsaka Hospital of Japan Seafarers relief AssociationOsaka Medical Center for Cancer and Cardiovascular DiseasesOsaka Medical College HospitalOsaka Police HospitalOsaka Prefectural Hospital Organization Osaka General Medical CenterOsaka Red Cross HospitalOsaka University HospitalOtsu Municipal HospitalOtsu Red Cross HospitalRakusei HospitalRyukyu University HospitalSaga University HospitalSaga-ken Medical Center KoseikanSaiseikai Fukushima General HospitalSaiseikai Hiroshima HospitalSaiseikai Kyoto HospitalSaiseikai Utsunomiya HospitalSaitama City HospitalSaitama Medical Center Jichi Medical UniversitySaitama Medical University HospitalSaitama Medical University Saitama International Medical CenterSaitama Medical University Saitama Medical CenterSaitama Medical CenterSakai City Medical CenterSaku Central HospitalSanin Rosai HospitalSano Kousei General HospitalSendai City HospitalShiga Medical Center for AdultsShiga University of Medical Science HospitalShikoku Cancer CenterShimada HospitalShimane University HospitalShimizu Welfare HospitalShinshu University HospitalShizuoka Cancer CenterShizuoka City Shizuoka HospitalShizuoka General HospitalShowa University HospitalShowa University Northern Yokohama HospitalShowa University Koto-Toyosu HospitalSocial Insurance Omuta Tenryo HospitalSocial Insurance Tagawa HospitalYokohama Chuo HospitalSonoda Daiichi HospitalSt. Marianna University School of Medical HospitalSt. Luke's International HospitalSugita Genpaku Memorial Obama Municipal HospitalSuita Municipal HospitalTakasago Municipal HospitalTakatsuki Red Cross HospitalTeikyo University HospitalTenri HospitalThe Cancer Institute Hospital of JFCRThe Jikei University HospitalThe Research Center Hospital for Charged Particle Therapy of NIRSToho University Omori Medical CenterToho University Sakura Medical CenterTohoku Kosai HospitalTohoku University HospitalTokai University Hachioji HospitalTokai University HospitalTokai University Tokyo HospitalTokushima Municipal HospitalTokushima Red Cross HospitalTokushima University HospitalTokyo Dental College Ichikawa General HospitalTokyo Medical and Dental University HospitalTokyo Medical University HospitalTokyo Medical University Ibaraki Medical CenterTokyo Metropolitan Cancer and Infectious Center Komagome HospitalTokyo Metropolitan Health and Medical Corporation Toshima HospitalTokyo University HospitalTokyo Women's Medical University HospitalTokyo Women's Medical University Medical Center EastTonan HospitalTone Chuou HospitalTottori Prefectural Central HospitalTottori University HospitalToyama Prefectural Central HospitalToyama University HospitalTsuchiura Kyodo HospitalTsukuba University HospitalTsuruoka Municipal Shonai Hospital"University Hospital, Kyoto Prefectural University of Medicine"University of Miyazaki HospitalWakayama Medical University HospitalYamagata Prefectural and Sakata Municipal Hospital OrganizationYamagata Prefectural Central HospitalYamagata Prefectural Shinjo HospitalYamagata University HospitalYamaguchi University HospitalYamaguchi-ken Saiseikai Shimonoseki General HospitalYamanashi Prefectural Central HospitalYamanashi University HospitalYao Municipal HospitalYokohama City Municipal HospitalYokohama City University HospitalYokohama City University Medical CenterYuri General Hospital(Total 276 institutions)

Patient Background {#Sec4}
==================

Table 1Age and genderAgeMaleFemaleUnknownCases (%)\~296107 (0.1 %)30--39126018 (0.3 %)40--49121340155 (2.5 %)50--5994617311120 (17.9 %)60--69233235402686 (42.9 %)70--79157527011846 (29.5 %)80--89303750378 (6.0 %)90\~163019 (0.3 %)Unknown274031 (0.5 %)Total533892026260 (100 %)Table 2Primary treatmentTreatmentsCases (%)Surgery3943 (63.0 %)Esophagectomy3844 (61.8 %)Palliative99 (1.2 %)Chemotherapy/radiotherapy1383 (22.1 %)Endoscopic treatment932 (14.9 %)Others2 (0.0 %)Total6260 (100 %)Table 3Tumor locationLocation of tumorEndoscopic treatment (%)Chemotherapy and/or radiotherapy (%)Palliative surgery (%)Esophagectomy (%)Other (%)Total (%)Cervical18 (1.9 %)112 (8.1 %)9 (9.1 %)137 (3.6 %)0276 (4.4 %)Upper thoracic105 (11.3 %)184 (13.3 %)19 (19.2 %)437 (11.4 %)0745 (11.9 %)Middle thoracic511 (54.8 %)665 (48.1 %)50 (50.5 %)1778 (46.3 %)1 (50.0 %)3005 (48.0 %)Lower thoracic243 (26.1 %)325 (23.5 %)18 (18.2 %)1147 (29.8 %)01733 (27.7 %)E \> G40 (4.3 %)38 (2.7 %)2 (2.0 %)245 (6.4 %)0325 (5.2 %)E = G5 (0.5 %)6 (0.4 %)041 (1.1 %)052 (0.8 %)G \> E02 (0.1 %)034 (0.9 %)036 (0.6 %)Unknown10 (1.1 %)51 (3.7 %)1 (1.0 %)25 (0.7 %)1 (50.0 %)88 (1.4 %)Total932 (100 %)1383 (100 %)99 (100 %)3844 (100 %)2 (100 %)6260 (100 %)*E* esophageal, *G* gastricTable 4Histologic types of biopsy specimensHistologic typesCases (%)Squamous cell carcinoma5665 (90.5 %)Squamous cell carcinoma3827 (61.1 %)Well differentiated354 (5.7 %)Moderately differentiated1140 (18.2 %)Poorly differentiated344 (5.5 %)Adenocarcinoma296 (4.7 %)Adenosquamous carcinoma13 (0.2 %)Mucoepidermoid carcinoma1 (0.0 %)Basaloid carcinoma22 (0.4 %)Neuroendocrine cell carcinoma14 (0.2 %)Undifferentiated carcinoma10 (0.2 %)Malignant melanoma7 (0.1 %)Carcinosarcoma17 (0.3 %)Other tumors28 (0.4 %)Unknown187 (3.0 %)Total6260 (100 %)Table 5Depth of tumor invasion, cT (UICC TNM 6th)cTCases (%)cTX29 (0.5 %)cT011 (0.2 %)cTis157 (2.5 %)cT1359 (5.7 %)cT1a650 (10.4 %)cT1b1134 (18.1 %)cT2868 (13.9 %)cT32252 (36.0 %)cT4701 (11.2 %)Unknown99 (1.6 %)Total6260 (100 %)Table 6Lymph node metastasis, cN (UICC TNM 6th)cNCases (%)cNX72 (1.2 %)cN02920 (46.6 %)cN13157 (50.4 %)Unknown111 (1.8 %)Total6260 (100 %)Table 7Distant metastasis, cM (UICC TNM 6th)cMCases (%)cMX57 (0.9 %)cM05295 (84.6 %)cM1223 (3.6 %)cM1a141 (2.3 %)cM1b466 (7.4 %)Total6260 (100 %)Table 8Clinical Stage (UICC TNM 6th)Location of tumorEndoscopic treatment (%)Chemotherapy and/or radiotherapy (%)Palliative surgery (%)Esophagectomy (%)Other (%)Total (%)0131 (14.1 %)6 (0.4 %)1 (1.0 %)13 (0.3 %)0151 (2.4 %)I658 (70.6 %)152 (11.0 %)2 (2.0 %)964 (25.1 %)01776 (28.4 %)IIA6 (0.6 %)125 (9.0 %)7 (7.1 %)717 (18.7 %)0855 (13.7 %)IIB7 (0.8 %)98 (7.1 %)2 (2.0 %)555 (14.4 %)0662 (10.6 %)III29 (3.1 %)452 (32.7 %)62 (62.6 %)1243 (32.3 %)1 (50.0 %)1787 (28.5 %)IV10 (1.1 %)139 (10.1 %)7 (7.1 %)44 (1.1 %)0200 (3.2 %)IVA5 (0.5 %)53 (3.8 %)1 (1.0 %)81 (2.1 %)0140 (2.2 %)IVB18 (1.9 %)265 (19.2 %)12 (12.1 %)156 (4.1 %)0451 (7.2 %)Unknown68 (7.3 %)93 (6.7 %)5 (5.1 %)71 (1.8 %)1 (50.0 %)238 (3.8 %)Total932 (100 %)1383 (100 %)99 (100 %)3844 (100 %)2 (100 %)6260 (100 %)

II. Results of endoscopically treated patients in 2009 {#Sec5}
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Table 9Details of endoscopic treatmentTreatment detailsCases (%)EMR201 (21.6 %)EMR + ESD11 (1.2 %)EMR + YAG laser7 (0.8 %)ESD607 (65.1 %)ESD + other treatment7 (0.8 %)PDT2 (0.2 %)PDT + YAG laser2 (0.2 %)YAG laser10 (1.1 %)Esophageal stenting70 (7.5 %)Esophageal stenting + tracheal stenting2 (0.2 %)Tracheal stenting4 (0.4 %)Others5 (0.5 %)Unknown4 (0.4 %)Total753 (100 %)*EMR* endoscopic mucosal resection, *ESD* endoscopic submucosal dissection, *YAG*: yttrium aluminum garnet, *PDT* photodynamic therapyTable 10Complications of EMR/ESDComplications of EMR/ESDCases (%)None766 (91.8 %)Perforation16 (1.9 %)Bleeding2 (0.2 %)Mediastinitis0Stenosis42 (5.0 %)Others7 (0.8 %)Unknown1 (0.1 %)Total834 (100 %)Table 11Pathological depth of tumor invasion of EMR/ESD specimensPathological depth of tumor invasionCases (%)pTX1 (0.1 %)pT05 (0.6 %)pTis166 (19.9 %)pT1a507 (60.9 %)pT1b86 (10.3 %)pT20Unknown68 (8.2 %)Total833 (100 %)

III. Results in patients treated with chemotherapy and/or radiotherapy in 2009 {#Sec6}
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Table 12Dose of radiation (non-surgically treated cases)Dose of radiation (Gy)DefinitivePalliative (%)Recurrence (%)Others (%)Unknown (%)Total (%)Radiation alone (%)With chemotherapy (%)--295 (4.1 %)18 (2.3 %)23 (11.0 %)2 (6.1 %)01 (5.6 %)49 (4.1 %)30--391 (0.8 %)15 (1.9 %)25 (11.9 %)3 (9.1 %)1 (7.1 %)045 (3.8 %)40--4911 (8.9 %)40 (5.1 %)31 (14.8 %)9 (27.3 %)8 (57.1 %)1 (5.6 %)100 (8.4 %)50--5924 (19.5 %)199 (25.3 %)47 (22.4 %)8 (24.2 %)2 (14.3 %)1 (5.6 %)281 (23.7 %)60--6974 (60.2 %)493 (62.6 %)81 (38.6 %)9 (27.3 %)2 (14.3 %)15 (83.3 %)674 (56.8 %)70-6 (7.2 %)8 (2.1 %)2 (0.0 %)00016 (2.2 %)Unknown2 (1.6 %)15 (1.9 %)1 (0.5 %)2 (6.1 %)1 (7.1 %)021 (1.8 %)Total123 (100 %)788 (100 %)210 (100 %)33 (100 %)14 (100 %)18 (100 %)1186 (100 %)Median (min--max)60.0 (6.0--120.0)60.0 (2.0--124.0)54.0 (2.0--95.4)50.0 (20.0--66.0)40.0 (36.0--60.0)60.0 (2.0--61.2)60.0 (2.0--124.0)Table 13Dose of radiation (surgically treated cases)Dose of radiation (Gy)Preoperative radiation (%)Postoperative radiation (%)--293 (1.4 %)1 (1.4 %)30--3954 (24.4 %)2 (2.7 %)40--49132 (59.7 %)21 (28.4 %)50--599 (4.1 %)18 (24.3 %)60--6915 (6.8 %)27 (36.5 %)70-00 (1.1 %)Unknown8 (3.6 %)5 (6.8 %)Total221 (100 %)74 (100 %)Median (min--max)40.0 (15.0--66.0)50.4 (4.0--64.0)

IV. Results in patients who underwent esophagectomy in 2009 {#Sec7}
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Table 14Treatment modalities of esophagectomyTreatmentsCases (%)Esophagectomy1630 (42.4 %)Esophagectomy + radiotherapy65 (1.7 %)Esophagectomy + chemoradiotherapy655 (17.0 %)Esophagectomy + chemoradiotherapy + endoscopic treatment16 (0.4 %)Esophagectomy + chemoradiotherapy + other treatment2 (0.1 %)Esophagectomy + radiotherapy + endoscopic treatment3 (0.1 %)Esophagectomy + radiotherapy + other treatment1 (0.0 %)Esophagectomy + chemotherapy1385 (36.0 %)Esophagectomy + chemotherapy + endoscopic treatment8 (0.2 %)Esophagectomy + chemotherapy + other treatment2 (0.1 %)Esophagectomy + endoscopic treatment77 (2.0 %)Total3844 (100 %)Table 15Tumor locationLocationsCases (%)Cervical137 (3.6 %)Upper thoracic437 (11.4 %)Middle thoracic1778 (46.3 %)Lower thoracic1147 (29.8 %)E \> G245 (6.4 %)E = G41 (1.1 %)G \> E34 (0.9 %)Unknown25 (0.7 %)Total lesions3844 (100 %)Table 16Approaches to tumor resectionApproachesCases (%)Cervical approach132 (3.4 %)Right thoracotomy3239 (84.3 %)Left thoracotomy66 (1.7 %)Left thoracoabdominal approach49 (1.3 %)Laparotomy148 (3.9 %)Transhiatal thoracic esophagectomy52 (1.4 %)Transhiatal lower esophagectomy92 (2.4 %)Sternotomy2 (0.1 %)Others32 (0.8 %)Unknown32 (0.8 %)Total3844 (100 %)Table 17Video-assisted surgeryVideo-assisted surgeryCases (%)None2549 (66.3 %)Thoracoscopy554 (14.4 %)Laparoscopy124 (3.2 %)Thoracoscopy + laparoscopy388 (10.1 %)Mediastinoscopy26 (0.7 %)Thoracoscopy + laparoscopy + mediastinoscopy4 (0.1 %)Thoracoscopy + other11 (0.3 %)Laparoscopy + mediastinoscopy5 (0.1 %)Others17 (0.4 %)Unknown166 (4.3 %)Total3844 (100 %)Table 18Fields of lymph node dissection according to the location of the tumorField of lymphadenectomyCervicalUpper thoracicMiddle thoracicLower thoracicE \> GE = GG \> EUnknownTotalNone9 (6.6 %)21 (4.8 %)76 (4.3 %)39 (3.4 %)5 (2.0 %)4 (9.8 %)1 (2.9 %)6 (75.0 %)161 (4.2 %)C51 (37.2 %)5 (1.1 %)13 (0.7 %)3 (0.3 %)0 (0.0 %)001 (12.5 %)73 (1.9 %)C + UM20 (14.6 %)5 (1.1 %)00000025 (0.7 %)C + UM + MLM7 (5.1 %)9 (2.1 %)45 (2.5 %)18 (1.6 %)2 (0.8 %)000 (0.0 %)81 (2.1 %)C + UM + MLM + A35 (25.5 %)286 (65.4 %)935 (52.6 %)435 (37.9 %)29 (11.8 %)3 (7.3 %)1 (2.9 %)8 (100.0 %)1732 (45.1 %)C + UM + MLM + A + other2 (1.5 %)4 (0.9 %)01 (0.1 %)00007 (0.2 %)C + UM + A0 (0.0 %)1 (0.2 %)1 (0.1 %)000002 (0.1 %)C + MLM + A02 (0.5 %)4 (0.2 %)4 (0.3 %)000010 (0.3 %)C + A5 (3.6 %)1 (0.2 %)3 (0.2 %)3 (0.3 %)0001 (12.5 %)13 (0.3 %)UM05 (1.1 %)4 (0.2 %)5 (0.4 %)000014 (0.4 %)UM + MLM2 (1.5 %)10 (2.3 %)17 (1.0 %)13 (1.1 %)2 (0.8 %)001 (12.5 %)45 (1.2 %)UM + MLM + A064 (14.6 %)584 (32.8 %)485 (42.3 %)81 (33.1 %)9 (22.0 %)5 (14.7 %)2 (25.0 %)1230 (32.0 %)UM + MLM + A + other00 (0.0 %)1 (0.1 %)000001 (0.0 %)UM + A01 (0.2 %)3 (0.2 %)3 (0.3 %)00007 (0.2 %)MLM03 (0.7 %)13 (0.7 %)5 (0.4 %)3 (1.2 %)000 (0.0 %)24 (0.6 %)MLM + A1 (0.7 %)12 (2.7 %)50 (2.8 %)104 (9.1 %)91 (37.1 %)16 (39.0 %)9 (26.5 %)3 (37.5 %)286 (7.4 %)A1 (0.7 %)5 (1.1 %)20 (1.1 %)24 (2.1 %)30 (12.2 %)9 (22.0 %)18 (52.9 %)0107 (2.8 %)Unknown4 (2.9 %)3 (0.7 %)9 (0.5 %)5 (0.4 %)2 (0.8 %)003 (37.5 %)26 (0.7 %)Total137 (100 %)437 (100 %)1778 (100 %)1147 (100 %)245 (100 %)41 (100 %)34 (100 %)25 (100 %)3844 (100 %)*C* bilateral cervical nodes, *UM* upper mediastinal nodes, *MLM* middle-lower mediastinal nodes, *A* abdominal nodesTable 19Reconstruction routeReconstruction routeCases (%)None48 (1.2 %)Subcutaneous323 (8.4 %)Retrosternal1422 (37.0 %)Intrathoracic446 (11.6 %)Posterior mediastinal1491 (38.8 %)Cervical49 (1.3 %)Others36 (0.9 %)Unknown29 (0.8 %)Total3844 (100 %)Table 20Organs used for reconstructionOrgans used for reconstructionCases (%)None51 (1.3 %)Whole stomach102 (2.6 %)Gastric tube3234 (81.6 %)Jejunum213 (5.4 %)Free jejunum88 (2.2 %)Colon153 (3.9 %)Free colon12 (0.3 %)Skin graft0 (0.0 %)Others93 (2.3 %)Unknown18 (0.5 %)Total organs3964 (100 %)Total cases3844Table 21Histological classificationHistological classificationCases (%)Squamous cell carcinoma3300 (86.7 %)　Squamous cell carcinoma685 (18.0 %)　Well differentiated653 (17.2 %)　Moderately differentiated1521 (40.0 %)　Poorly differentiated441 (11.6 %)Adenocarcinoma222 (5.8 %)Adenosquamous cell carcinoma35 (0.9 %)Adenoid cystic carcinoma1 (0.0 %)Basaloid carcinoma56 (1.5 %)Neuroendocrine cell carcinoma17 (0.4 %)Undifferentiated carcinoma10 (0.3 %)Other carcinoma9 (0.2 %)Carcinosarcoma21 (0.6 %)Malignant melanoma11 (0.3 %)GIST1 (0.0 %)Other46 (1.2 %)Unknown78 (2.0 %)Total3807 (100 %)Table 22Depth of tumor invasion, pT (JES 10th)pT categoryCases (%)pTX24 (0.6 %)pT094 (2.4 %)pTis29 (0.8 %)pT1a422 (11.0 %)pT1b1065 (27.7 %)pT2454 (11.8 %)pT31518 (39.5 %)pT4127 (3.3 %)pT4a27 (0.7 %)pT4b30 (0.8 %)Unknown54 (1.4 %)Total3844 (100 %)Table 23Pathological grading of lymph node metastasis, pN (JES 10th)Lymph node metastasisCases (%)pN02270 (59.1 %)pN1492 (12.8 %)pN2584 (15.2 %)pN3225 (5.9 %)pN4185 (4.8 %)Unknown88 (2.3 %)Total3844 (100 %)Table 24Numbers of the metastatic nodesNumbers of lymph node metastasisCases (%)01779 (46.3 %)1-2985 (25.6 %)3-6640 (16.6 %)7-376 (9.8 %)Unknown64 (1.7 %)Total3844 (100 %)Table 25Pathological findings of distant organ metastasis, pM (JES 10th)Distant metastasisCases (%)pMX53 (1.4 %)pM03733 (97.1 %)pM158 (1.5 %)Total3844 (100 %)Table 26Residual tumor, RResidual tumorCases (%)RX156 (4.1 %)R03345 (87.0 %)R1187 (4.9 %)R2156 (4.1 %)Total3844 (100 %)Table 27Causes of deathCause of deathCases (%)Death due to recurrence1139 (72.8 %)Death due to other cancer65 (4.2 %)Death due to other disease (rec +)44 (2.8 %)Death due to other disease (rec-)179 (11.4 %)Death due to other disease (rec?)7 (0.4 %)Operative death\*39 (2.5 %)Postoperative hospital death\*\*40 (2.6 %)Unknown52 (3.3 %)Total of death cases1565 (100 %)rec recurrence\* Operative death means death within 30 days after operation in or out of hospital\*\* Hospital death is defined as death during the same hospitalization, regardless of department at time of deathOperative mortality after esophagectomy: 1.01 %Hospital mortality after esophagectomy: 4.76 % ![](10388_2016_531_Figa_HTML.gif){#d30e5659}

These data were first made available on January 2016, as the Comprehensive Registry of Esophageal Cancer in Japan, 2009. Not all the tables and figures are reprinted here.
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